DK3370692T3 - Sammensætning til frigørelse af tilstoppet næse med antiviral aktivitet - Google Patents
Sammensætning til frigørelse af tilstoppet næse med antiviral aktivitet Download PDFInfo
- Publication number
- DK3370692T3 DK3370692T3 DK16738419.7T DK16738419T DK3370692T3 DK 3370692 T3 DK3370692 T3 DK 3370692T3 DK 16738419 T DK16738419 T DK 16738419T DK 3370692 T3 DK3370692 T3 DK 3370692T3
- Authority
- DK
- Denmark
- Prior art keywords
- release
- composition
- antiviral activity
- clogged nose
- clogged
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/731—Carrageenans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15176670 | 2015-07-14 | ||
PCT/EP2016/066565 WO2017009351A1 (en) | 2015-07-14 | 2016-07-12 | Stuffy nose deblocking composition having antiviral activity |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3370692T3 true DK3370692T3 (da) | 2023-06-26 |
Family
ID=53717900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16738419.7T DK3370692T3 (da) | 2015-07-14 | 2016-07-12 | Sammensætning til frigørelse af tilstoppet næse med antiviral aktivitet |
Country Status (27)
Country | Link |
---|---|
US (1) | US10660914B2 (da) |
EP (1) | EP3370692B1 (da) |
JP (1) | JP6774435B2 (da) |
KR (1) | KR102628781B1 (da) |
CN (1) | CN107847430B (da) |
AU (1) | AU2016293004B2 (da) |
BR (1) | BR112018000592B1 (da) |
CA (1) | CA2992352C (da) |
CL (1) | CL2018000033A1 (da) |
DK (1) | DK3370692T3 (da) |
EA (1) | EA037085B1 (da) |
ES (1) | ES2949139T3 (da) |
FI (1) | FI3370692T3 (da) |
HK (1) | HK1253038A1 (da) |
HU (1) | HUE062108T2 (da) |
IL (1) | IL256883B (da) |
LT (1) | LT3370692T (da) |
MA (1) | MA43155A (da) |
MX (1) | MX2018000285A (da) |
MY (1) | MY194870A (da) |
NZ (1) | NZ738597A (da) |
PH (1) | PH12018500044A1 (da) |
PL (1) | PL3370692T3 (da) |
PT (1) | PT3370692T (da) |
SA (1) | SA518390689B1 (da) |
WO (1) | WO2017009351A1 (da) |
ZA (1) | ZA201708595B (da) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180108811A (ko) * | 2016-02-17 | 2018-10-04 | 이엔티 테크놀로지스 피티와이 리미티드 | 부비강 질환 및 장애의 치료를 위한 조성물 및 방법 |
GB2567285A (en) * | 2017-08-07 | 2019-04-10 | Suprapharm Cc | Preparation for nasal-nasopharyngeal treatment |
US20230120864A1 (en) | 2020-03-12 | 2023-04-20 | Sydney David Cullis-Hill | Treatment for coronavirus infection and associated cytokine toxicity |
CN111437270A (zh) * | 2020-04-24 | 2020-07-24 | 瑞希(重庆)生物科技有限公司 | 一种卡拉胶鼻用即型凝胶喷雾剂及其制备方法 |
US11013687B1 (en) | 2020-06-08 | 2021-05-25 | Amcyte Pharma, Inc. | Preventive and therapeutic treatment for COVID 19 and any other disease caused by SARS CoV 2 |
WO2021253643A1 (zh) * | 2020-06-18 | 2021-12-23 | 大连工业大学 | 硫酸化多糖在抗新型冠状病毒中的应用 |
CN111686125A (zh) * | 2020-06-18 | 2020-09-22 | 大连工业大学 | 卡拉胶在抗新型冠状病毒中的应用 |
EP3939597A1 (en) * | 2020-07-16 | 2022-01-19 | Marinomed Biotech AG | Antiviral pharmaceutical composition comprising a carrageenan component |
US20230330013A1 (en) | 2020-08-04 | 2023-10-19 | Cosmosoft | Hydrogel comprising glycerol and a carbomer for treating the respiratory symptoms of covid-19 disease via the nasal route |
FR3113237B1 (fr) | 2020-08-04 | 2023-06-09 | Biopass | Produit pour le traitement de maladies virales par voie nasale |
EP3991561A1 (en) * | 2020-10-28 | 2022-05-04 | Vepidan ApS | Antimicrobial disinfectant gel |
GB202109888D0 (en) | 2021-07-08 | 2021-08-25 | Pollinner Ltd | Nasal spray |
KR20230094472A (ko) * | 2021-12-21 | 2023-06-28 | (주)메디코어 | 비강 세정제 조성물 및 그 제조방법 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2653021A1 (fr) * | 1989-10-17 | 1991-04-19 | Merck Sharp & Dohme | Composition ophtalmique aqueuse liquide a transition de phase liquide-gel. |
US6080783A (en) * | 1998-09-01 | 2000-06-27 | Gum Tech International, Inc. | Method and composition for delivering zinc to the nasal membrane |
DK2522365T3 (da) * | 2004-11-24 | 2017-02-06 | Meda Pharmaceuticals Inc | Sammensætninger, der omfatter azelastin, og metoder til brug deraf |
US20080241271A1 (en) * | 2006-11-08 | 2008-10-02 | Roman Stephen B | Foaming anti-adhesion composition |
PL2101792T3 (pl) | 2006-12-05 | 2010-11-30 | Marinomed Biotechnologie Gmbh | Zastosowanie karageniny do leczenia zakażeń rinowirusem |
BRPI0815748B8 (pt) | 2007-08-24 | 2021-05-25 | Marinomed Biotechnologie Gmbh | uso de iota-carragenina em uma quantidade antiviral eficaz |
FR2926218B1 (fr) | 2008-01-10 | 2010-08-13 | Galderma Res & Dev | Composition comprenant un retinoide et du peroxyde de benzoyle disperse. |
WO2013049538A1 (en) | 2011-09-30 | 2013-04-04 | Mcneil-Ppc, Inc. | Allergen nasal compositions |
-
2016
- 2016-07-12 DK DK16738419.7T patent/DK3370692T3/da active
- 2016-07-12 AU AU2016293004A patent/AU2016293004B2/en active Active
- 2016-07-12 CA CA2992352A patent/CA2992352C/en active Active
- 2016-07-12 US US15/767,273 patent/US10660914B2/en active Active
- 2016-07-12 MY MYPI2017704939A patent/MY194870A/en unknown
- 2016-07-12 EA EA201890196A patent/EA037085B1/ru unknown
- 2016-07-12 LT LTEPPCT/EP2016/066565T patent/LT3370692T/lt unknown
- 2016-07-12 WO PCT/EP2016/066565 patent/WO2017009351A1/en active Application Filing
- 2016-07-12 ES ES16738419T patent/ES2949139T3/es active Active
- 2016-07-12 MX MX2018000285A patent/MX2018000285A/es active IP Right Grant
- 2016-07-12 PL PL16738419.7T patent/PL3370692T3/pl unknown
- 2016-07-12 EP EP16738419.7A patent/EP3370692B1/en active Active
- 2016-07-12 MA MA043155A patent/MA43155A/fr unknown
- 2016-07-12 NZ NZ738597A patent/NZ738597A/en unknown
- 2016-07-12 FI FIEP16738419.7T patent/FI3370692T3/fi active
- 2016-07-12 KR KR1020187004269A patent/KR102628781B1/ko active IP Right Grant
- 2016-07-12 JP JP2017565990A patent/JP6774435B2/ja active Active
- 2016-07-12 CN CN201680039448.1A patent/CN107847430B/zh active Active
- 2016-07-12 BR BR112018000592-4A patent/BR112018000592B1/pt active IP Right Grant
- 2016-07-12 PT PT167384197T patent/PT3370692T/pt unknown
- 2016-07-12 HU HUE16738419A patent/HUE062108T2/hu unknown
-
2017
- 2017-12-18 ZA ZA2017/08595A patent/ZA201708595B/en unknown
-
2018
- 2018-01-03 SA SA518390689A patent/SA518390689B1/ar unknown
- 2018-01-04 PH PH12018500044A patent/PH12018500044A1/en unknown
- 2018-01-05 CL CL2018000033A patent/CL2018000033A1/es unknown
- 2018-01-11 IL IL256883A patent/IL256883B/en unknown
- 2018-09-27 HK HK18112418.9A patent/HK1253038A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3370692T3 (da) | Sammensætning til frigørelse af tilstoppet næse med antiviral aktivitet | |
DK3340213T3 (da) | Puf-baseret kompositsikkerhedsmærkning til bekæmpelse af vareforfalskning | |
DK3356350T3 (da) | Isoindolinonhæmmere af mdm2-p53-interaktionen med anticanceraktivitet | |
DK3096741T3 (da) | Fremgangsmåde til fremstillingen af hybridosomer | |
DK3137169T3 (da) | Hæmmere af lysin-specifik demethylase-1 | |
DK3294720T3 (da) | Fremgangsmåde til fremstilling af terpinolenepoxid | |
DK3161154T3 (da) | Modificerede polymeraser til forbedret inkorporering af nukleotidanaloger | |
DK3127300T3 (da) | Håndtering af nic-krypterede flows til at migrere gæster eller opgaver | |
DK3180331T3 (da) | Polymorfer af selinexor | |
DK3317400T3 (da) | Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter | |
DK3174858T3 (da) | Fremgangsmåde til fremstilling af pyrazoler | |
DK3325443T3 (da) | Fremgangsmåde til fremstilling af pridopidin | |
DK3373758T3 (da) | Fremgangsmåde til fremstilling af beklædningsgenstande med elastiske lynlåse | |
DK3685847T3 (da) | Modulatorer af komplementaktivitet | |
DK3233813T3 (da) | Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser | |
DK3125871T3 (da) | Fremstilling af peptidladede plga-mikrosfærer med kontrolleret frigivelse-kendetegn | |
DK3176906T3 (da) | Tostrenget batteriløsning til backcup af datacenter | |
DK3297653T3 (da) | Behandling af postbariatrisk hypoglykæmi med glp-1-antagonister | |
DK3280408T3 (da) | Fremgangsmåde til fremstilling af dicycloplatin | |
DK3114235T3 (da) | Fremgangsmåde til bestemmelse af risiko for 5-fluorouracil-toksicitet | |
DK3377484T3 (da) | Fremgangsmåder til behandling af multipel sklerose under anvendelse af pyrimidin- og pyridinforbindelser med btk- inhiberende aktivitet | |
DK3191498T3 (da) | Fremgangsmåde til fremstilling af 2'-o-fucosyllactose | |
DK3390422T3 (da) | Krystalformer af lnt | |
DK3185867T3 (da) | Krystalliseringsfremgangsmåde af aripiprazolderivater i forlængede frigivelsesformuleringer til behandling af skizofreni | |
DK3227325T3 (da) | Sammensætninger med selektive hæmmere af il-6-trans-signalering |